of cardiac contractility the greater-than-normal force of contraction in the beat following an extrasystole was described in 1885 by Langendorff,' although the term itself was first used by Hoffman in 1956.2 As reviewed by Cranefield,3 initial studies of this phenomenon in isolated heart muscle and in intact heart preparations demonstrated that PESP is a fundamental characteristic of both normal and depressed mammalian myocardium.
POSTEXTRASYSTOLIC POTENTIATION (PESP) of cardiac contractility the greater-than-normal force of contraction in the beat following an extrasystole was described in 1885 by Langendorff,' although the term itself was first used by Hoffman in 1956.2 As reviewed by Cranefield,3 initial studies of this phenomenon in isolated heart muscle and in intact heart preparations demonstrated that PESP is a fundamental characteristic of both normal and depressed mammalian myocardium.
Although the strength of the postectopic beat is dependent on the prematurity of the ectopic beat,3' the fundamental mechanism of the potentiation is unclear. Current concepts are that the primary enhancement of myocardial contractility in both the intact heart and in isolated isometrically contracting muscle is unrelated to changes in fiber length and probably reflects an increased availability of calcium at the contractile sites. However, in the intact heart, cardiac performance is also augmented by the reduction in aortic impedance to ejection that results from the decline in aortic pressure during the compensatory pause. The compensatory pause also allows increased diastolic filling. Thus, the augmentation of cardiac performance in the intact heart results from these two indirect effects of PESP as well as its direct effect on the contractile mechanism.
The effect of PESP on left ventricular systolicfunction has been investigated using several hemodynamic measurements, including pressure responses, isovolumic and ejection phase indexes of contractility and regional wall motion shortening. Because PESP is an important aspect of the force-interval relationship (the dependence of cardiac contractility on the rate and pattern of stimulation), it has also been used by Anderson et al. 5 to determine a force-interval ratio that can be used as an index of contractility. Ratios were lowest in patients with increased left ventricular chamber size and end-diastolic pressure. In addition to systolic function, the effect of PESP on diastolic function has also been studied. Two of the most recent studies deserve particular comment. Kuijer et al.8 demonstrated that PESP apparently had no effect on relaxation parameters such as the time constant of pressure decline and dP/dt min (negative dP/dt). Gaasch et al.,7 using ultrasonic segment length crystals in dogs and contrast ventriculography and high-fidelity pressure measurement in humans, found no difference between the overall pressure-length or pressure-volume plots when control diastolic data were compared with data from the diastole immediately after an extrasystole. Although PESP caused no alteration in the modulus of chamber stiffness, the increased filling during the postextrasystolic pause did cause the ventricle to operate higher on the steep (stiffer) portion of the pressurevolume curve.
The possibilities of using PESP therapeutically were explored in studies using continuous paired electrical stimulation, which resulted in a marked enhancement of myocardial contractility.8 Although in ischemic myocardium the initial augmentation could not be sustained," the enhancement of contractility suggested that PESP after a single paired stimulus might be helpful in identifying viable but poorly perfused myocardium and, in the decade since the original paired electrical stimulation studies, several different groups of investigators have tested the diagnostic usefulness of PESP. One type of investigation has examined acute myocardial ischemia in the canine model; another type has evaluated chronic myocardial ischemia in humans. This editorial is primarily concerned with this aspect of PESPevaluating inotropic contractile reserve in ischemic heart disease, both acute and chronic.
Acute Myocardial Ischemia
Dyke et al.'0 extensively explored the possibility that PESP might serve to identify viable but poorly perfused myocardium. A caliper length gauge was used to record segmental shortening and left ventricular pressure was used to construct pressure-length loops. During acute regional ischemia, PESP consistently augmented segmental function and abolished dyskinesis. Unlike PESP, pharmacologic agents either worsened segmental function or caused responses that were minimal and inconsistent. Thus, these studies demonstrated that PESP was superior to pharmacologic inotropic stimulation (with calcium or isoproterenol) in demonstrating viable ischemic myocardium. Boden et al." used the technique to assess the progression of regional contraction abnormalities in a canine model with occlusion of the left anterior descending coronary artery. Pressure-length loops were constructed in normal, border and VOL 61, No 6, JUNE 1980 ischemic zones. Despite a 50% decrease in border-zone segment function, PESP consistently returned mechanical performance to control levels. Even in the central necrotic zone, with its aneurysmal bulging, PESP could markedly augment performance, though not up to control levels. In these studies, ischemia was maintained for 10 minutes or less. In their most recent studies,'2 which appear in this issue, these investigators also show similar results with more prolonged periods of coronary occlusion. Open-chest dogs were subjected to 4-hour left anterior descending coronary artery ligation and then 1 hour of reperfusion. Before reperfusion, PESP augmented borderzone segment performance to control levels and improved central ischemic zone function, though not to control levels. Reperfusion improved both intrinsic and potentiated mechanical performance in border and ischemic zones. As the authors note, their studies and those of Dyke et al.'0 are at variance with reports'3' 14 from investigators at the University of California at San Diego. This latter group demonstrated lack of potentiation of isometric left ventricular tension development in acutely ischemic areas'3 and more recently14 showed a rapid loss of potentiation of regional shortening during the first few minutes of ischemia in the central zone and a marked decline of PESP in the marginal areas during prolonged ischemia. Boden et al.12 cite some of the differences in technique that may account for the discrepancies, but further studies are needed to resolve this issue.
Diamond et al."5 have reported that atrial premature beats could also induce PESP and were useful in defining the magnitude and duration of latent contractility in an acutely ischemic canine preparation. It is not clear whether atrial PESP is comparable to that obtained with ventricular extrasystoles because no direct comparisons were made. This warrants further study because introduction of atrial extrasystoles may be easier and safer in humans than ventricular extrasystoles.
Chronic Ischemic Heart Disease Invasive Studies
At the Peter Bent Brigham Hospital, there has been particular interest in demonstrating inotropic contractile reserve in patients with coronary artery disease.
After the initial animal studies cited earlier,'0 human studies were performed in the cardiac catheterization laboratory and involved ventriculographic analyses, especially ejection fraction and segmental shortening.'6 In most patients, an R-wave-coupled stimulator and right ventricular pacing catheter were used to introduce the premature ventricular contraction. In these investigations, significant improvement in segmental function was shown by augmentation of shortening in hypkinetic zones, often with improvement to normal ranges, and induced contraction in akinetic or dyskinetic zones, although rarely to normal values. These studies determined that PESP is a stimulation during ventriculography in humans, and also that it could better demonstrate the presence of presumably viable but ischemic myocardium than the catecholamines previously used.17 Simitar results with PESP were subsequently reported by Hamby et al.18 In their studies, the extrasystoles were not programmed, but occurred as a result of the injection of contrast material. (This techniqueor that in which right ventricular extrasystoles are induced by catheter irritation is acceptable as long as the compensatory pause is long enough. The site of origin of the ventricular extrasystoles does not appear to influence PESP.) Anderson et al.5 evaluated echocardiographic minor-axis shortening during PESP using atrial pacing and found the response to PESP was useful in determining force-interval relationships for patients with varying degrees of left ventricular dysfunction.
PESP has also been compared with the effects of nitroglycerin in improving contractile reserve.'9 21
Two ventriculograms are performed, one with PESP (with ventricular extrasystoles occurring as a result of contrast injection), and the other after nitroglycerin administration. In some series, PESP was also recorded during the nitroglycerin ventriculogram. In these studies the results in patients with ischemic myocardium were similar with either intervention. Nitroglycerin is not an inotropic stimulus, however, so normal zones did not respond to the drug, whereas they did respond to PESP with increased contraction. In the study by Banka et al.,'9 12 of 13 hypokinetic zones improved with both nitroglycerin and PESP alone; one was unchanged with either. Interestingly, six asynergic zones that had responded to nitroglycerin alone showed further augmentation with nitroglycerin plus PESP. However, in the study by Klausner et al.,20 the combination of nitroglycerin and PESP did not cause augmentation greater than that with either intervention alone. Furthermore, this group did not find a relationship between the compensatory pause and the change in contractility with PESP. The intrinsic variability and sensitivity of the angiographic measurements is probably a factor in the discrepancy. Klausner et al.20 confirmed an early angiographic study by Markis et al.22 that specifically addressed this issue. Markis et al. observed that there were no significant changes in PESP of ejection fraction in the same patient despite coupling intervals that varied from 370-610 msec. Thus, it is probably fair to say that in regard to angiographic studies, PESP may be considered as an "all-or-none" phenomenon in terms of augmentation of ejection fraction or regional shortening. Why certain zones are responsive to inotropic stimulation or afterload reduction has been extensively studied by Helfant's group and was summarized in a recent review.23 Important factors that suggest fibrotic scar rather than ischemic myocardium are Q waves on the ECG, the severity of asynergy, and the degree of coronary occlusion and, in some situations, inadequate or absent coronary collaterals. In addition, safe, effective and convenient form of inotropic In addition to improved segmental function after revascularization surgery, the response to inotropic stimulation can also be directly correlated with perioperative morbidity and mortality. The ejection fraction is a useful prognostic indication, but PESP gives it greater value. Thus, in patients with a depressed ejection fraction at rest, i.e., less than 0.50, an increase in global ejection fraction of 0.10 or more (by either PESP or catecholamines) was associated with significantly better results than smaller degrees of augmentation.27 This response to PESP has been used as an aid in selecting patients with left ventricular dysfunction for myocardial revascularization.28 Furthermore, medically treated patients with this degree of augmentation also did better than did their counterparts, at least in the short term.27 Follow-up studies in these patients are continuing, both to evaluate long-term prognosis as well as the viability of the revascularized zones. In addition to wall motion changes, there has also been interest in the change in the aortic pressure-pulse contour after PESP. In one study,29 100 consecutive patients with coronary artery disease were evaluated. Patients whose systolic pressure in the postextrasystolic beat was similar to or lower than that in the control beat had a lower prevalence of congestive heart failure and cardiomegaly compared with patients in whom the systolic pressure in the postextrasystolic beat was higher than in the control beat. These findingsthat a potentiated pressure response is more readily demonstrated in the presence of myocardial dysfunctionare similar to those of several other studies involving patients with a variety of heart diseases.30 32 The interplay of aortic impedance and stroke volume contributes to the systolic pressure level in the potentiated beat. Many patients with left ventricular dysfunction have a lower baseline stroke volume and therefore are capable of a relatively greater increase in this value. Furthermore, these patients have compensated for a chronically decreased stroke volume (and cardiac output) by an increased peripheral vascular resistance (to maintain blood pressure). In this setting, PESP may lead to pronounced rises in systolic blood pressure. Similarly, systolic time intervals derived from the aortic pressure contour also have been reported to show the greatest augmentation in the presence of left ventricular dysfunction.33 When indices of contractility derived pressure curve are evaluated, however (such as left ventricular dP/dt or Vmax),34' 35 the effects of PESP are similar to those noted when regional and global ejection phase indices are measured; marked augmentation is seen in both normal control subjects and coronary artery disease patients without left ventricular dysfunction. In the presence of left ventricular dysfunction, the response is variable, depending on the degree of contractile reserve and presumably to what extent the left ventricular dysfunction is due to myocardial fibrosis.
What of the electrocardiographic changes associated with PESP? Engel and associates38 studied the effect on the ECG of PESP and noted that postextrasystolic T-wave changes (alteration in vector, amplitude or contour compared with sinus beats) were present in 68% of normal controls as well as 81% of subjects with coronary disease. Within the coronary artery disease group, left ventricular asynergy and degree of vascular disease were not associated with an increased frequency of these ECG changes.
Noninvasive Studies
A technique has recently been made available to measure the effects of PESP on left ventricular function noninvasively. This technique depends on an external mechanical cardiac stimulator (developed by Zoll et al. 37 ) that can safely elicit ventricular extrasystoles noninvasively while echocardiographic measurements are made. In one study,38 overall global contractile reserve was measured in patients with a variety of heart diseases. Systolic dimensional shortening and ejection fraction were measured. The degree of PESP was very reproducible in repeat studies and when the same patients were evaluated at cardiac catheterization. In another series of patients with coronary artery disease who were studied with the same techniques,39 the reversibility of localized abnormalities of wall motion was investigated. Septal and posterior wall motion abnormalities were shown to be usually, but not always, irreversible in the presence of coronary artery lesions and corresponding Q waves on the ECG. As in the ventriculography studies, normal myocardium, as well as ischemic but viable myocardial segments, were augmented by PESP.
Future Directions
Fundamental issues must be clarified concerning the relationship between alterations in calcium fluxes and the enhancement of myocardial contractility by PESP. Is the effect of atrial rather than ventricular extrasystoles on these alterations similar? In addition, the basis for the marked response of systolic pressure to PESP in some patients with left ventricular dysfunction requires further clarification. In patients with left ventricular dysfunction due to nonischemic disease, does the PESP improvement in ejection fraction (whether determined by echocar-diography38 or contrast ventriculography40) have the from the isovolumic part of the left ventricular 1073 same important prognostic implications as it appears 1074 CIRCULATION to have in coronary artery disease? In relation to ischemic heart disease specifically, the effect of PESP on relaxation has yet to be intensively studied, but PESP has been of value in the study of systolic function in acute myocardial ischemia and may help to resolve some of the controversies concerning the presence and extent of the border zone around a myocardial infarction. When used during cardiac catheterization in humans, PESP has been useful in clarifying reversibility of ischemic segments of myocardium in patients with chronic coronary disease, and should continue to be of value in selecting patients for revascularization surgery. Perhaps the most exciting clinical potential for this diagnostic tool lies in the noninvasive areas, where the coupling of the external stimulating device to the two-dimensional echocardiographic technique is presently under investigation, and where further advances in radionuclide ventriculography may permit PESP to be employed during that procedure as well. points on the left ventricular volume curve (usually end-systole and end-diastole), because quantitative analysis of regional performance for the entire cardiac cycle is exceedingly time-consuming with standard angiographic techniques. Yet there is reason to suspect that ventricular contraction and the alterations in contraction that occur as a result of coronary artery disease and other pathologic processes might best be understood in terms of the sequential changes in regional myocardial contraction and relaxation that occur throughout the cardiac cycle."-" With the development of gated equilibrium radionuclide ventriculography and with the validation of regional ejection fraction as a quantitative index of left ventricular performance,8' 9 it is possible to quantitatively assess regional left ventricular performance at multiple intervals during the cardiac cycle. In the present study, we analyzed and characterized regional asynchrony, and determined its incidence in patients with coronary artery disease.
Materials and Methods

Patient Population
The study group consisted of 40 consecutive patients referred to the Peter Bent Brigham Hospital for
